230 results · 34ms · Sources: EU EUDAMED, US FDA

QUANTAZYME TOXOPLASMA

FDA 510(k)
FDA Class 2 ·Microbiology

LIQUICHEK ANTI-SS-B CONTROL, POSITIVE, CATALOG #113

FDA 510(k)
FDA Class 2 ·Immunology

VARIANT II TOTAL GHB

FDA 510(k)
FDA Class 2 ·Hematology

QUANTIMUNE TOBRAMYCIN RIA RADIOIMMUNO

FDA 510(k)
FDA Class 2 ·Clinical Toxicology

LIQUICHEK ANA CONTROL, CENTROMERE PATTERN, MODEL 203

FDA 510(k)
FDA Class 2 ·Immunology

LIQUICHEK ANTI-MITOCHONDRIAL CONTROL, POSITIVE, CATALOG #127

FDA 510(k)
FDA Class 2 ·Immunology

DIGILAB MICRO ONE APPLANATION TONOMETER

FDA 510(k)
FDA Class 2 ·Ophthalmic

DIAMAT GLYCOSLATED HEMOGLOBIN ANALYZER SYSTEM

FDA 510(k)
FDA Class 2 ·Hematology

LIQUICHEK ANTI-SCL-70 CONTROL, POSITIVE, CATALOG #116

FDA 510(k)
FDA Class 2 ·Immunology

BENZODIAZEPINES BY REMEDI HS

FDA 510(k)
FDA Class 2 ·Clinical Toxicology

PROCEDURE, RED CELL FOLATE ASSAY

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

LIQUICHEK ANA CONTROL, EIA SCREEN, MODEL 205

FDA 510(k)
FDA Class 2 ·Immunology

VARIANT EXPRESS GLYCOHEMOGLOBIN PROGRAM

FDA 510(k)
FDA Class 2 ·Clinical Toxicology

QUANTIMUNE T-4 FIA

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

LYPHOCHEK COAGULATION CONTROL

FDA 510(k)
FDA Class 2 ·Hematology

VARIANT(TM) HEMOGLOBIN A 1C PROGRAM

FDA 510(k)
FDA Class 2 ·Hematology

REMEDI(TM) DRUG PROFILING SYSTEM, MODIFICATION

FDA 510(k)
FDA Class 2 ·Clinical Toxicology

PLATELIA LYME IGM

FDA 510(k)
FDA Class 2 ·Microbiology

LIQUICHEK ANA CONTROL, NUCLEOLAR PATTERN, MODEL 204

FDA 510(k)
FDA Class 2 ·Immunology

PROCEDURE, RA, THYROXINE BINDING PROTEIN

FDA 510(k)
FDA Class 2 ·Clinical Chemistry